| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 410,025 | 353,556 | 484,245 | 472,642 | | Cost of Revenue | (13,808) | 127,267 | 172,158 | 217,993 | | | Gross Profit | 423,833 | 226,289 | 312,087 | 254,649 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 46,198 | 70,005 | 66,028 | 27,473 | | Non Recurring | 9,330 | 86,436 | 21,466 | 73,005 | | Others | 158,027 | 164,123 | 195,531 | 192,409 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 210,278 | (94,275) | 29,062 | (38,238) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (112) | | Earnings Before Interest And Taxes | 35,228 | (94,275) | 29,062 | (44,597) | | Interest Expense | 43,438 | 43,475 | 41,138 | 40,154 | | Income Before Tax | (8,210) | (137,750) | (12,076) | (84,751) | | Income Tax Expense | (2,532) | (43,876) | (1,263) | (22,280) | | Minority Interest |
-
| 3,793 | (3,793) | (6,247) | | | | Net Income From Continuing Ops | (5,678) | (90,081) | (14,606) | (62,471) | | | Non-recurring Events | | Discontinued Operations | 12,107 | 1,761 |
-
| (2,996) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,840) | (88,320) | (14,606) | (65,467) | | Preferred Stock And Other Adjustments | 3,271 | (3,271) |
-
|
-
| | | Net Income Applicable To Common Shares | ($2,569) | ($91,591) | ($14,606) | ($65,467) |
|
1.52% Nasdaq 
Income Statement
